During the past decade, Forbes Norris MDA/ALS Research Center conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 8 clinical trials were completed, i.e. on average, 88.9% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 7 clinical trials were completed. i.e. 140% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Forbes Norris MDA/ALS Research Center" #1 sponsor was "Cytokinetics" with 6 trials, followed by "Amylyx Pharmaceuticals Inc." with 2 trials sponsored, "Knopp Biosciences" with 2 trials sponsored, "Calico Life Sciences LLC" with 1 trials sponsored and "Janssen Research & Development, LLC" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Forbes Norris MDA/ALS Research Center" #1 collaborator was "ALS Association" with 1 trials as a collaborator, "ALS Finding a Cure" with 1 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "Institute for Ethnomedicine" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Forbes Norris MDA/ALS Research Center" are "Amyotrophic Lateral Sclerosis" (10 trials), "Amyotrophic Lateral Sclerosis (ALS)" (3 trials), "ALS" (1 trials), "Central Nervous System Diseases" (1 trials) and "Motor Neuron Disease" (1 trials). Many other conditions were trialed in "Forbes Norris MDA/ALS Research Center" in a lesser frequency.

Most popular intervention types in "Forbes Norris MDA/ALS Research Center" are "Drug" (14 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Reldesemtiv" (3 trials), "AMX0035" (2 trials), "Placebo tablets" (2 trials) and "ABBV-CLS-7262" (1 trials). Other intervention names were less common.

The vast majority of trials in "Forbes Norris MDA/ALS Research Center" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Forbes Norris MDA/ALS Research Center". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Forbes Norris MDA/ALS Research Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Forbes Norris MDA/ALS Research Center, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".